agilon health, inc. (NYSE:AGL) Receives Consensus Recommendation of “Moderate Buy” from Analysts

agilon health, inc. (NYSE:AGL – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the ten research firms that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $28.63.

Several research analysts recently issued reports on AGL shares. Guggenheim lifted their target price on agilon health from $21.00 to $30.00 and gave the company a “buy” rating in a research report on Monday, March 6th. Stifel Nicolaus assumed coverage on agilon health in a research report on Thursday, December 8th. They issued a “buy” rating and a $23.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on agilon health from $26.00 to $28.00 in a research report on Friday, March 3rd.

Insider Buying and Selling at agilon health

In other agilon health news, insider Benjamin Kornitzer sold 5,398 shares of the business’s stock in a transaction on Friday, December 16th. The stock was sold at an average price of $16.82, for a total value of $90,794.36. Following the sale, the insider now directly owns 10,426 shares in the company, valued at $175,365.32. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, insider Benjamin Shaker sold 28,555 shares of the business’s stock in a transaction on Wednesday, February 15th. The stock was sold at an average price of $23.37, for a total transaction of $667,330.35. Following the sale, the insider now directly owns 25,625 shares in the company, valued at approximately $598,856.25. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Benjamin Kornitzer sold 5,398 shares of the business’s stock in a transaction on Friday, December 16th. The shares were sold at an average price of $16.82, for a total value of $90,794.36. Following the sale, the insider now owns 10,426 shares in the company, valued at $175,365.32. The disclosure for this sale can be found here. Insiders have sold a total of 70,864 shares of company stock worth $1,515,177 over the last ninety days. 3.30% of the stock is currently owned by company insiders.

Institutional Trading of agilon health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. FMR LLC increased its stake in agilon health by 14.9% in the 2nd quarter. FMR LLC now owns 34,862,287 shares of the company’s stock worth $761,043,000 after acquiring an additional 4,512,008 shares during the last quarter. Vanguard Group Inc. increased its stake in agilon health by 14.7% in the 3rd quarter. Vanguard Group Inc. now owns 18,770,560 shares of the company’s stock worth $439,605,000 after acquiring an additional 2,407,116 shares during the last quarter. Durable Capital Partners LP increased its stake in agilon health by 34.0% in the 3rd quarter. Durable Capital Partners LP now owns 9,429,055 shares of the company’s stock worth $220,828,000 after acquiring an additional 2,392,134 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of agilon health by 11.0% in the 1st quarter. Wellington Management Group LLP now owns 18,578,035 shares of the company’s stock worth $470,953,000 after purchasing an additional 1,834,890 shares in the last quarter. Finally, Capital Research Global Investors boosted its holdings in shares of agilon health by 18.4% in the 1st quarter. Capital Research Global Investors now owns 9,867,875 shares of the company’s stock worth $250,151,000 after purchasing an additional 1,536,506 shares in the last quarter.

agilon health Stock Up 1.0 %

Shares of NYSE:AGL opened at $23.91 on Thursday. The stock has a market cap of $9.88 billion, a price-to-earnings ratio of -91.96 and a beta of 1.09. The company has a quick ratio of 2.71, a current ratio of 2.71 and a debt-to-equity ratio of 0.04. agilon health has a 12-month low of $14.82 and a 12-month high of $28.36. The business’s 50 day moving average is $21.55 and its 200 day moving average is $20.34.

agilon health Company Profile

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.